ADGRB1 and neoplasm: They demonstrated in an in vivo tumor model (subcutaneous inoculation of the RCC cell line Renca) that ADGRB1 overexpression in Renca reduced tumor growth due to reduced microvessel density which was associated with reduced VEGF expression levels (Kudo et al., 2007).